Syndecan 1 (CD138) serum levels: A novel biomarker in predicting liver fibrosis stage in patients with hepatitis C

Isabel Zvibel*, Phillipe Halfon, Sigal Fishman, Guillaume Penaranda, Moshe Leshno, Anat Bet Or, Zamir Halpern, Ran Oren

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Syndecan 1 (CD138) serum levels: A novel biomarker in predicting liver fibrosis stage in patients with hepatitis C'. Together they form a unique fingerprint.

Medicine & Life Sciences